TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
477,364
|
325,756
|
222,081 |
| Financial expenses |
127
|
5
|
30 |
| Earnings before taxes |
101,288
|
52,301
|
32,238 |
| EBITDA |
98,665
|
51,202
|
32,467 |
| Total assets |
346,837
|
238,857
|
135,346 |
| Current assets |
345,531
|
237,838
|
134,345 |
| Current liabilities |
229,606
|
173,871
|
92,928 |
| Equity capital |
115,702
|
63,666
|
35,562 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
50
|
48
|
42 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
33.4%
|
26.7%
|
26.3% |
| Turnover per employee |
9,547
|
6,787
|
5,288 |
| Profit as a percentage of turnover |
21.2%
|
16.1%
|
14.5% |
| Return on assets (ROA) |
29.2%
|
21.9%
|
23.8% |
| Current ratio |
150.5%
|
136.8%
|
144.6% |
| Return on equity (ROE) |
87.5%
|
82.1%
|
90.7% |
| Change turnover |
162,383
|
102,532
|
86,374 |
| Change turnover % |
52%
|
46%
|
64% |
| Chg. No. of employees |
2
|
6
|
5 |
| Chg. No. of employees % |
4%
|
14%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.